ADC Therapeutics
Crena Solop has extensive experience in the field of technical accounting. Crena is currently working as the Director of Technical Accounting at ADC Therapeutics since November 2020. Prior to that, they worked at Celgene, where they held various roles including Associate Director, Senior Manager, and Manager of Technical Accounting from August 2015 to November 2020. Before joining Celgene, Crena worked at L-3 Communications as the Internal Audit Manager and Senior Internal Auditor from June 2013 to July 2015. Crena began their career at KPMG Audit as a Second Year Associate from September 2008 to March 2010.
Crena Solop obtained a Bachelor of Science degree in Accounting from Montclair State University, completing their education from 2004 to 2008.
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.